Comparison Overview

Editora FÓRUM

VS

The Center for Biosimilars

Editora FÓRUM

Rua Paulo Ribeiro Bastos 211, Belo Horizonte, Minas Gerais, 31710-430, BR
Last Update: 2025-11-26

Com o objetivo de oferecer os melhores títulos do segmento editorial jurídico, a Editora Fórum especializou-se no gênero do Direito Público e encontra-se, hoje, em lugar de destaque no mercado.A empresa, presidida pelo Dr. Luis Cláudio Rodrigues Ferreira, está em atuação desde 1992. Nesse período já foram publicados mais de 500 títulos, reunindo cerca de 1500 autores. Além disso, é a Editora que mais publica periódicos na área de Direito Público no país, mantendo atualmente 21 periódicos, sendo 5 projetos customizados.Em seus livros e periódicos estão presentes estudos de Doutrina e Jurisprudência nas áreas do Direito Administrativo, Ambiental, Constitucional, Disciplinar, Econômico, Eleitoral, de Estado, Financeiro, Internacional, Municipal, Previdenciário, Processual, Regulatório, Sanitário, das Telecomunicações, do Terceiro Setor, Urbanístico e Tributário

NAICS: 511
NAICS Definition:
Employees: 85
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

The Center for Biosimilars

undefined, Cranbury, NJ, undefined, undefined
Last Update: 2025-11-26

Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.

NAICS: 511
NAICS Definition:
Employees: 2
Subsidiaries: 57
12-month incidents
0
Known data breaches
1
Attack type number
2

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/editora-f-rum-ltda.jpeg
Editora FÓRUM
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/thecenterforbiosimilars.jpeg
The Center for Biosimilars
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Editora FÓRUM
100%
Compliance Rate
0/4 Standards Verified
The Center for Biosimilars
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Editora FÓRUM in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for The Center for Biosimilars in 2025.

Incident History — Editora FÓRUM (X = Date, Y = Severity)

Editora FÓRUM cyber incidents detection timeline including parent company and subsidiaries

Incident History — The Center for Biosimilars (X = Date, Y = Severity)

The Center for Biosimilars cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/editora-f-rum-ltda.jpeg
Editora FÓRUM
Incidents

No Incident

https://images.rankiteo.com/companyimages/thecenterforbiosimilars.jpeg
The Center for Biosimilars
Incidents

Date Detected: 08/2022
Type:Cyber Attack
Blog: Blog

Date Detected: 5/2018
Type:Breach
Attack Vector: Unauthorized Access
Blog: Blog

FAQ

Editora FÓRUM company demonstrates a stronger AI Cybersecurity Score compared to The Center for Biosimilars company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

The Center for Biosimilars company has historically faced a number of disclosed cyber incidents, whereas Editora FÓRUM company has not reported any.

In the current year, The Center for Biosimilars company and Editora FÓRUM company have not reported any cyber incidents.

Neither The Center for Biosimilars company nor Editora FÓRUM company has reported experiencing a ransomware attack publicly.

The Center for Biosimilars company has disclosed at least one data breach, while Editora FÓRUM company has not reported such incidents publicly.

The Center for Biosimilars company has reported targeted cyberattacks, while Editora FÓRUM company has not reported such incidents publicly.

Neither Editora FÓRUM company nor The Center for Biosimilars company has reported experiencing or disclosing vulnerabilities publicly.

Neither Editora FÓRUM nor The Center for Biosimilars holds any compliance certifications.

Neither company holds any compliance certifications.

The Center for Biosimilars company has more subsidiaries worldwide compared to Editora FÓRUM company.

Editora FÓRUM company employs more people globally than The Center for Biosimilars company, reflecting its scale as a Book and Periodical Publishing.

Neither Editora FÓRUM nor The Center for Biosimilars holds SOC 2 Type 1 certification.

Neither Editora FÓRUM nor The Center for Biosimilars holds SOC 2 Type 2 certification.

Neither Editora FÓRUM nor The Center for Biosimilars holds ISO 27001 certification.

Neither Editora FÓRUM nor The Center for Biosimilars holds PCI DSS certification.

Neither Editora FÓRUM nor The Center for Biosimilars holds HIPAA certification.

Neither Editora FÓRUM nor The Center for Biosimilars holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.